Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors

Diamyd Medical today announced that Karin Rosén, M.D, Ph.D, San Francisco, will join the Board of Directors as an adjunct member, and be proposed for election to the Board at its next General Meeting of Shareholders. Dr. Rosén has deep experience from the biotechnology industry with more than two decades of working in senior leadership positions in global clinical development and U.S. and global medical affairs across her time with Horizon Therapeutics, GSK (GlaxoSmithKline), Aimmune Therapeutics and  Genentech, a member of the Roche group.“We are thrilled to welcome Dr. Rosén to Diamyd